Cisplatin, Paclitaxel, and Gemcitabine in Treating Patients With Progressive Unresectable Regional or Metastatic Bladder Cancer

NCT00006118 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

OTHER

Sponsor class

Conditions

Bladder Cancer

Interventions

DRUG: cisplatin
DRUG: gemcitabine hydrochloride
DRUG: paclitaxel

Sponsor

GERCOR - Multidisciplinary Oncology Cooperative Group